Jinxin Fertility Group Limited (HKG:1951)

Hong Kong · Delayed Price · Currency is HKD

2.140

+0.015 (0.71%)

Sep 23, 2026, 4:08 PM HKT

Market Cap	5.60B -24.5%
Revenue (ttm)	3.16B +2.9%
Net Income	197.58M
EPS	0.07
Shares Out	2.62B
PE Ratio	30.95
Forward PE	16.32
Dividend	0.04 (2.02%)
Ex-Dividend Date	Jun 29, 2026

Volume	7,296,000
Open	2.150
Previous Close	2.125
Day's Range	2.120 - 2.160
52-Week Range	1.920 - 2.910
Beta	0.80
Analysts	Buy
Price Target	3.19 (+49.07%)
Est. Earnings	Nov 20, 2026

About Jinxin Fertility Group

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and internationally. The company provides two treatment solutions, including artificial insemination that is performed with either husband’s sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also related services, such as nutrition guidance, Chinese medicine treatment, and psychological cou... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 1951

Employees 3,128

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 1951

Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

Analyst Summary

According to 14 analysts, the average rating for 1951 stock is "Buy." The 12-month stock price target is $3.19, which is an increase of 49.07% from the latest price.

Price Target

$3.19

(49.07% upside)

Analyst Consensus: Buy

Stock Forecasts